Novartis Acquiring Ziarco Group For Eczema Medicine


Novartis is basically the biggest competitor of Pfizer as far as pharmaceutical companies are concerned. Pfizer recently inked a deal with Anacor to acquire an FDA-approved drug that can be used to treat eczema. Well, rival Novartis decided to answer that call with their own acquisition. They are planning to buy Ziarco for its eczema medicine.

novartis eczema pill

Ziarco has been running trials and they’ve also been attempting to raise a round of capital to further advance into new trial phases. The deal was said to be worth about $1 billion in total.

Novartis is essentially acquiring this drug with chances of it never actually making it to the marketplace. However, that’s a chance they seem to be willing to take just to keep in mine with the other gorilla in the room.

According to a recent publication, Vasant Narasimhan had a few things to say about the acquisition stating that, “There is an unmet need for innovative, effective and safe oral treatment options for people living with eczema.” Vasant Narasimhan is the global head of drug development and CMO of Novartis. More than likely, he has information and data at his disposal that many others simply do not have. Therefore, it’s important that we not take what he says lightly.

Novartis AG, Inc. was formed in 1996 and remains the holding company for many pharmaceuticals on the market today. They do a ton of stuff with regards to the industry. Everything from research, development, manufacturing, marketing and more. There’s a good chance that many individuals suffering from eczema are going to feel a sense of relief when they read this article. No, not because they’ve figured it out, but instead because they are continuing to put forth the effort to do so.

If you’re personally suffering from eczema, then I strongly encourage you to do your research on various products that can help relieve discomfort you may be having. Chances are this simple once a day pill will not be available for quite some time. Don’t be discouraged though, at least they are putting forth the effort, resources, and energy to make many people’s dream a reality.

If you want to learn more about the condition, then I encourage you to read this page here for more information. I’m sure that I’m not alone when I say that we all wish that there was one simple pill that we could take to fix or cure just about anything on this planet. Unfortunately, that’s not the case. On a more positive note, every day we are getting closer and closer.

Novartis Acquiring Ziarco Group For Eczema Medicine
Rate this post
Brandon Sirrico


Brandon Sirrico is a well-versed marketing expert with a background in finance. He holds an MBA from Florida International University and an undergrad from Northeastern. A former bodybuilder, he's a dedicated gym rat who provides many updates on health and diet as well as reactions to trending skin care topics.